Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management.
Reny, Jean-Luc
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. [electronic resource] - Cardiovascular therapeutics Feb 2012 - e41-50 p. digital
Publication Type: Journal Article; Review
1755-5922
10.1111/j.1755-5922.2010.00248.x doi
Acute Coronary Syndrome--blood
Angioplasty, Balloon, Coronary--adverse effects
Drug Resistance--genetics
Drug Therapy, Combination
Guideline Adherence
Hemorrhage--chemically induced
Humans
Patient Selection
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--adverse effects
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Treatment Outcome
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. [electronic resource] - Cardiovascular therapeutics Feb 2012 - e41-50 p. digital
Publication Type: Journal Article; Review
1755-5922
10.1111/j.1755-5922.2010.00248.x doi
Acute Coronary Syndrome--blood
Angioplasty, Balloon, Coronary--adverse effects
Drug Resistance--genetics
Drug Therapy, Combination
Guideline Adherence
Hemorrhage--chemically induced
Humans
Patient Selection
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--adverse effects
Practice Guidelines as Topic
Risk Assessment
Risk Factors
Treatment Outcome